Personalized Medicine - Going for the Sure Cure | Jos Joore | TEDxBinnenhof

MIMETAS – Organ-on-a-chip cell culture models for more reliable and tailored medicines.

Jos is a driven and creative professional, between market and science. Jos holds a cum laude Master’s degree in business marketing, a Ph.D. in developmental biology and a Master’s degree in biology.

Jos is a biotech entrepreneur, with over seventeen years of executive level biotech experience in a variety of companies; Pepscan, Skyline Diagnostics, Kreatech, and Westburg. He is a co-founder of 4 companies; Mimetas, Pepscope, Spreekmeester, and Kopla. Mimetas develops predictive organ-on-a-chip cell culture models for better, more reliable and tailored medicines.

[tomsawyer]

"The potential to deliver 'one shot cures' is one of the most attractive aspects of gene therapy, genetically-engineered cell therapy and gene editing. However, such treatments offer a very different outlook with regard to recurring revenue versus chronic therapies, " analyst Salveen Richter wrote in the note to clients Tuesday. "While this proposition carries tremendous value for patients and society, it could represent a challenge for genome medicine developers looking for sustained cash flow."
From Goldman Sachs this week.